tetano
Editor, Senior Moderator
Viruses
. 2021 Apr 21;13(5):723.
doi: 10.3390/v13050723.
SARS-CoV-2 and Placenta: New Insights and Perspectives
Leonardo Resta[SUP] 1 [/SUP], Antonella Vimercati[SUP] 2 [/SUP], Gerardo Cazzato[SUP] 1 [/SUP], Giulia Mazzia[SUP] 1 [/SUP], Ettore Cicinelli[SUP] 2 [/SUP], Anna Colagrande[SUP] 1 [/SUP], Margherita Fanelli[SUP] 3 [/SUP], Sara Vincenza Scarcella[SUP] 1 [/SUP], Oronzo Ceci[SUP] 1 [/SUP], Roberta Rossi[SUP] 1 [/SUP]
Affiliations
Abstract
The study of SARS-CoV-2 positive pregnant women is of some importance for gynecologists, obstetricians, neonatologists and women themselves. In recent months, new works have tried to clarify what happens at the fetal-placental level in women positive for the virus, and different pathogenesis mechanisms have been proposed. Here, we present the results of a large series of placentas of Coronavirus disease (COVID) positive women, in a reference center for COVID-positive pregnancies, on which we conducted histological, immunohistochemical and electron microscopy investigations. A case-control study was conducted in order to highlight any histopathological alterations attributable to SARS-CoV-2. The prevalence of maternal vascular malperfusion was not significantly different between cases and controls (54.3% vs. 43.7% p = 0.19), whereas the differences with regard to fetal vascular malperfusion (21.1% vs. 4.2% p < 0.001) were significant. More frequent in cases with respect to controls were decidual arteriopathy (40.9% vs. 1.4% p < 0.0001), decidual inflammation (32.4% vs. 0.7% p < 0.0001), perivillous fibrin deposition (36.6% vs. 3.5% p < 0.0001) and fetal vessel thrombi (22.5% vs. 0.7% p < 0.0001). No significant differences in the percentage of terminal villous hyperplasia and chorioamnionitis were observed between the two groups. As the pandemic continues, these studies will become more urgent in order to clarify the possible mechanism of maternal-fetal transmission of the virus.
Keywords: COVID-19; SARS-CoV-2; outcomes; placenta; pregnancy; transmission; viruses.
. 2021 Apr 21;13(5):723.
doi: 10.3390/v13050723.
SARS-CoV-2 and Placenta: New Insights and Perspectives
Leonardo Resta[SUP] 1 [/SUP], Antonella Vimercati[SUP] 2 [/SUP], Gerardo Cazzato[SUP] 1 [/SUP], Giulia Mazzia[SUP] 1 [/SUP], Ettore Cicinelli[SUP] 2 [/SUP], Anna Colagrande[SUP] 1 [/SUP], Margherita Fanelli[SUP] 3 [/SUP], Sara Vincenza Scarcella[SUP] 1 [/SUP], Oronzo Ceci[SUP] 1 [/SUP], Roberta Rossi[SUP] 1 [/SUP]
Affiliations
- PMID: 33919284
- DOI: 10.3390/v13050723
Abstract
The study of SARS-CoV-2 positive pregnant women is of some importance for gynecologists, obstetricians, neonatologists and women themselves. In recent months, new works have tried to clarify what happens at the fetal-placental level in women positive for the virus, and different pathogenesis mechanisms have been proposed. Here, we present the results of a large series of placentas of Coronavirus disease (COVID) positive women, in a reference center for COVID-positive pregnancies, on which we conducted histological, immunohistochemical and electron microscopy investigations. A case-control study was conducted in order to highlight any histopathological alterations attributable to SARS-CoV-2. The prevalence of maternal vascular malperfusion was not significantly different between cases and controls (54.3% vs. 43.7% p = 0.19), whereas the differences with regard to fetal vascular malperfusion (21.1% vs. 4.2% p < 0.001) were significant. More frequent in cases with respect to controls were decidual arteriopathy (40.9% vs. 1.4% p < 0.0001), decidual inflammation (32.4% vs. 0.7% p < 0.0001), perivillous fibrin deposition (36.6% vs. 3.5% p < 0.0001) and fetal vessel thrombi (22.5% vs. 0.7% p < 0.0001). No significant differences in the percentage of terminal villous hyperplasia and chorioamnionitis were observed between the two groups. As the pandemic continues, these studies will become more urgent in order to clarify the possible mechanism of maternal-fetal transmission of the virus.
Keywords: COVID-19; SARS-CoV-2; outcomes; placenta; pregnancy; transmission; viruses.